Grace Therapeutics (GRCE) Cash & Current Investments (2017 - 2026)
Grace Therapeutics (GRCE) recorded Cash & Current Investments of $13.76 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 617.2% from $1.92 million a year earlier but down 19.0% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Cash & Current Investments (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Cash & Current Investments of $16.98 million, down 23.3% from FY2025.
- Annual Cash & Current Investments has declined for five straight fiscal years, with a five-year compound annual growth rate of -22.5% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Current Investments came in at $22.13 million in FY2025 (-3.8%), $23.01 million in FY2024 (-17.5%), $27.89 million in FY2023 (-36.1%) and $43.66 million in FY2022 (-28.1%).
- Quarterly Cash & Current Investments has ranged from $1.92 million in fiscal Q1 2026 to $50.79 million in fiscal Q2 2022 over the past five years.
- On a year-over-year basis, Cash & Current Investments rose in three of the last eight quarters, with growth averaging 60.0%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 617.2% in fiscal Q1 2027, against a decline of 90.1% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $16.98 million (Q4 2026), $18.67 million (Q3 2026) and $16.86 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Grace Therapeutics | 33.33 Mn | -32.94 Mn | - | 13.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.76 Mn |
| Mar 31, 2026 | 16.98 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 16.86 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 22.13 Mn |
| Dec 31, 2024 | 11.06 Mn |
| Sep 30, 2024 | 15.17 Mn |
| Jun 30, 2024 | 19.41 Mn |
| Mar 31, 2024 | 23.01 Mn |
| Dec 31, 2023 | 25.11 Mn |
| Sep 30, 2023 | 27.01 Mn |
| Jun 30, 2023 | 21.65 Mn |
| Mar 31, 2023 | 27.89 Mn |
| Dec 31, 2022 | 31.26 Mn |
| Sep 30, 2022 | 34.94 Mn |
| Jun 30, 2022 | 38.39 Mn |
| Mar 31, 2022 | 43.66 Mn |
| Dec 31, 2021 | 46.33 Mn |
| Sep 30, 2021 | 50.79 Mn |
API Access
Grace Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();